A REVIEW OF NEW DRUGS APPROVED BY THE SPANISH AGENCY OF MEDICINES AND MEDICAL DEVICES (AEMPS): A QUICK METHOD TO EXPLORE THERAPEUTIC INNOVATION

被引:0
|
作者
Pejenaute, A. [1 ]
Ramos, N. [1 ]
Arnaiz, J. A. [2 ,3 ]
Garcia-Cinca, D. [1 ]
Calvo, G. [2 ,3 ]
机构
[1] Fundacio Clin Recerca Biomed, Barcelona, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
[3] Univ Barcelona, Barcelona, Spain
关键词
D O I
10.1016/j.clinthera.2015.05.434
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:E151 / E152
页数:2
相关论文
共 5 条
  • [1] ROLE OF THE SPANISH AGENCY FOR MEDICINES AND MEDICAL DEVICES (AEMPS) IN THE ASSESSMENT OF CENTRALISED MEDICINAL PRODUCTS
    Alonso-Gutierrez, A.
    Sulleiro-Avendano, E.
    Padilla-Gallego, M. E.
    Diaz-Ramos, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 51
  • [2] CLINICAL TRIALS AUTHORISED BY THE SPANISH AGENCY OF MEDICINES AND MEDICAL DEVICES IN 2013. CONCLUSIONS OF AEMPS AND RESEARCH ETHICS COMMITTEE
    Quijada Manuitt, M. A.
    Perez Bravo, L. A.
    Serrano Castro, M. A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 24 - 24
  • [3] Is it necessary to modify the normative of medical research when drugs are not the study objective? Response from the Spanish Agency of Medicines and Health Devices
    de la Fuente Honrubia, Cesar
    Macias Saint-Gerons, Diego
    Montero Corominas, Dolores
    MEDICINA CLINICA, 2012, 138 (12): : 546 - 547
  • [4] A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)
    Gnanasakthy, Ari
    Levy, Courtney
    Norcross, Lindsey
    Doward, Lynda
    Winnette, Randall
    VALUE IN HEALTH, 2023, 26 (06) : 893 - 901
  • [5] Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020
    Outterson, Kevin
    Orubu, Ebiowei S. F.
    Rex, John
    Ardal, Christine
    Zaman, Muhammad H.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (07) : 1183 - 1190